"Consumers and health care professionals will soon find updated labeling for extended-release and long-acting opioid pain relievers to help ensure their safe and appropriate use.
In addition to requiring new labeling on these prescript"...
Becauseofthemildanti-cho-linergic effect of orphenadrine, Orphengesic (orphenadrine citrate, asprin and caffeine tablets) Tablets, or Or-phengesicForteTabletsshould not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostat-ic hypertrophy orobstructions at the bladder neck. Orphen-gesic Tablets or Orphengesic (orphenadrine citrate, asprin and caffeine tablets) Forte Tablets are also contraindicated in patients withmy-astheniagravis and in patients known to be sensitive to aspirin or caffeine.
The drug is contraindicated in patients who have demonstrated a previous hypersensi-tivitytothe drug.
Last reviewed on RxList: 12/17/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Orphengesic Information
Report Problems to the Food and Drug Administration
Chronic Pain/Back Pain
Find tips and advances in treatment.